The purpose of this study is to evaluate the efficacy and the safety of silodosin in urinary calculi patients.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
300
Japan
Tokyo and Other Japanese City, Japan
Spontaneous stone passage rate
Time frame: 4 weeks
Time to spontaneous stone passage
Time frame: 4 weeks
Analgesic use
Time frame: 4 weeks
Pain severity
Time frame: 4 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.